Literature DB >> 17553882

Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5.

Simon N Waddington1, Alan L Parker, Menzo Havenga, Stuart A Nicklin, Suzanne M K Buckley, John H McVey, Andrew H Baker.   

Abstract

Vitamin K-dependent coagulation factors can promote adenoviral cell transduction in vitro. In vivo, warfarin pretreatment ablates liver targeting of an adenovirus serotype 5 (Ad5) vector deleted of CAR binding capability. Here, we assess in vivo transduction and biodistribution of Ad5 vectors with nonmodified fibers (Ad5) and a serotype 47 fiber-pseudotyped Ad5 (Ad5/47; subgroup D) virus following intravascular injection. Warfarin reduced liver transduction by both viruses. However, no impact on early liver virus accumulation was observed, suggesting no effect on Kupffer cell interactions. Hence, coagulation factors play a pivotal role in selectively mediating liver hepatocyte transduction of Ad5 and Ad5/47 vectors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553882      PMCID: PMC1951445          DOI: 10.1128/JVI.00663-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.

Authors:  D A Einfeld; R Schroeder; P W Roelvink; A Lizonova; C R King; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo.

Authors:  P N Reynolds; S A Nicklin; L Kaliberova; B G Boatman; W E Grizzle; I V Balyasnikova; A H Baker; S M Danilov; D T Curiel
Journal:  Nat Biotechnol       Date:  2001-09       Impact factor: 54.908

3.  The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction.

Authors:  C J Cohen; J T Shieh; R J Pickles; T Okegawa; J T Hsieh; J M Bergelson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

4.  Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

Authors:  M J E Havenga; A A C Lemckert; O J A E Ophorst; M van Meijer; W T V Germeraad; J Grimbergen; M A van Den Doel; R Vogels; J van Deutekom; A A M Janson; J D de Bruijn; F Uytdehaag; P H A Quax; T Logtenberg; M Mehtali; A Bout
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Titer determination of Ad5 in blood: a cautionary note.

Authors:  G Cichon; S Boeckh-Herwig; D Kuemin; C Hoffmann; H H Schmidt; E Wehnes; W Haensch; U Schneider; U Eckhardt; R Burger; P Pring-Akerblom
Journal:  Gene Ther       Date:  2003-06       Impact factor: 5.250

6.  Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.

Authors:  K Oka; L Pastore; I H Kim; A Merched; S Nomura; H J Lee; M Merched-Sauvage; C Arden-Riley; B Lee; M Finegold; A Beaudet; L Chan
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

7.  Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases.

Authors:  Dmitry M Shayakhmetov; Zong-Yi Li; Shaoheng Ni; André Lieber
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

8.  A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.

Authors:  P N Reynolds; K R Zinn; V D Gavrilyuk; I V Balyasnikova; B E Rogers; D J Buchsbaum; M H Wang; D J Miletich; W E Grizzle; J T Douglas; S M Danilov; D T Curiel
Journal:  Mol Ther       Date:  2000-12       Impact factor: 11.454

9.  CD46 is a cellular receptor for group B adenoviruses.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; André Lieber
Journal:  Nat Med       Date:  2003-10-19       Impact factor: 53.440

10.  Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D.

Authors:  Alan L Parker; John H McVey; Jessica H Doctor; Oscar Lopez-Franco; Simon N Waddington; Menzo J E Havenga; Stuart A Nicklin; Andrew H Baker
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

View more
  39 in total

1.  Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.

Authors:  Raul Alba; Angela C Bradshaw; Lynda Coughlan; Laura Denby; Robert A McDonald; Simon N Waddington; Suzanne M K Buckley; Jenny A Greig; Alan L Parker; Ashley M Miller; Hongjie Wang; Andre Lieber; Nico van Rooijen; John H McVey; Stuart A Nicklin; Andrew H Baker
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

2.  Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

Authors:  Raul Alba; Angela C Bradshaw; Alan L Parker; David Bhella; Simon N Waddington; Stuart A Nicklin; Nico van Rooijen; Jerome Custers; Jaap Goudsmit; Dan H Barouch; John H McVey; Andrew H Baker
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

3.  Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells.

Authors:  Mari I Jonsson; Annasara E Lenman; Lars Frängsmyr; Cecilia Nyberg; Mohamed Abdullahi; Niklas Arnberg
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

4.  FX and host defense evasion tactics by adenovirus.

Authors:  Andrew H Baker; Stuart A Nicklin; Dmitry M Shayakhmetov
Journal:  Mol Ther       Date:  2013-06       Impact factor: 11.454

5.  Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Authors:  Zhili Xu; Jie Tian; Jeffrey S Smith; Andrew P Byrnes
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

6.  With a little help from my f(X)riends!: the basis of Ad5-mediated transduction of the liver revealed.

Authors:  Pedro R Lowenstein
Journal:  Mol Ther       Date:  2008-06       Impact factor: 11.454

7.  Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.

Authors:  Reeti Khare; Shannon M May; Francesco Vetrini; Eric A Weaver; Donna Palmer; Amanda Rosewell; Nathan Grove; Philip Ng; Michael A Barry
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

8.  Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.

Authors:  Jenny A Greig; Suzanne Mk Buckley; Simon N Waddington; Alan L Parker; David Bhella; Rebecca Pink; Ahad A Rahim; Takashi Morita; Stuart A Nicklin; John H McVey; Andrew H Baker
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

9.  Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells.

Authors:  Cynthia Lyle; Frank McCormick
Journal:  Virol J       Date:  2010-07-08       Impact factor: 4.099

Review 10.  The role of liver sinusoidal cells in hepatocyte-directed gene transfer.

Authors:  Frank Jacobs; Eddie Wisse; Bart De Geest
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.